Publication | Closed Access

How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience

OncologyRadiation TherapyMedicineStage Iii NsclcSingle-centre ExperienceCancer TreatmentLung CancerRadiation OncologyCancer MetabolismNuclear MedicineTumor MicroenvironmentRadiologyHealth Sciences